Lv41
640 积分 2024-03-21 加入
Oral peptide delivery: Translational challenges due to physiological effects
14小时前
待确认
Retracted: Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
14小时前
待确认
Prevalence of Chronic Kidney Disease in China
4天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
5天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
5天前
已完结
Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
7天前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
7天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
7天前
已完结
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
7天前
已完结
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
7天前
已完结
Single and combined treatment processes for rhodamine B removal by coagulation–flocculation and adsorption
皖公网安备34019202002308
